Incorporation of albumin fusion proteins into fibrin clots in vitro and in vivo: comparison of different fusion motifs recognized by factor XIIIa

BACKGROUND: The transglutaminase activated factor XIII (FXIIIa) acts to strengthen pathological fibrin clots and to slow their dissolution, in part by crosslinking active α(2)-antiplasmin (α(2)AP) to fibrin. We previously reported that a yeast-derived recombinant fusion protein comprising α(2)AP res...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheffield, William P, Eltringham-Smith, Louise J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258216/
https://www.ncbi.nlm.nih.gov/pubmed/22185689
http://dx.doi.org/10.1186/1472-6750-11-127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258216/
https://www.ncbi.nlm.nih.gov/pubmed/22185689
http://dx.doi.org/10.1186/1472-6750-11-127

Ejemplares similares